Nerve Growth Factor for the Treatment of Spinocerebellar Ataxia Type 3: An Open-label Study

BACKGROUND: Spinocerebellar ataxia type 3 (SCA3) is the most common subtype of SCA worldwide, and runs a slowly progressive and unremitting disease course. There is currently no curable treatment available. Growing evidence has suggested that nerve growth factor (NGF) may have therapeutic effects in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Song, Wang, Rui-Hao, Niu, Hui-Xia, Shi, Chang-He, Mao, Cheng-Yuan, Zhang, Rui, Song, Bo, Sun, Shi-Lei, Liu, Xin-Jing, Hou, Hai-Man, Liu, Yu-Tao, Gao, Yuan, Fang, Hui, Kong, Xiang-Dong, Xu, Yu-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837856/
https://www.ncbi.nlm.nih.gov/pubmed/25635421
http://dx.doi.org/10.4103/0366-6999.150087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837856/
https://www.ncbi.nlm.nih.gov/pubmed/25635421
http://dx.doi.org/10.4103/0366-6999.150087

Ejemplares similares